Related Experiment Video
Updated: Jan 26, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Transiently proliferating perivascular microglia harbor M1 type and precede cerebrovascular changes in a chronic
Takashi Koizumi1, Katsutoshi Taguchi2, Ikuko Mizuta1
1Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho Kamigyo-ku, Kyoto, 602-8566, Japan.
Background:
Microglia play crucial roles in the maintenance of brain homeostasis. Activated microglia show a biphasic influence, promoting beneficial repair and causing harmful damage via M2 and M1 microglia, respectively. It is well-known that microglia are initially activated to the M2 state and subsequently switch to the M1 state, called M2-to-M1 class switching in acute ischemic models. However, the activation process of microglia in chronic and sporadic hypertension remains poorly understood. We aimed to clarify the process using a chronic hypertension model, the deoxycorticosterone acetate (DOCA)-salt-treated Wistar rats.
Methods:
After unilateral nephrectomy, the rats were randomly divided into DOCA-salt, placebo, and control groups. DOCA-salt rats received a weekly subcutaneous injection of DOCA (40 mg/kg) and were continuously provided with 1% NaCl in drinking water. Placebo rats received a weekly subcutaneous injection of vehicle and were provided with tap water. Control rats received no administration of DOCA or NaCl. To investigate the temporal expression profiles of M1- and M2-specific markers for microglia, the animals were subjected to the immunohistochemical and biochemical studies after 2, 3, or 4 weeks DOCA-salt treatment.
Results:
Hypertension occurred after 2 weeks of DOCA and salt administration, when round-shaped microglia with slightly shortened processes were observed juxtaposed to the vessels, although the histopathological findings were normal. After 3 weeks of DOCA and salt administration, M1-state perivascular and parenchyma microglia significantly increased, when local histopathological findings began to be observed but cerebrovascular destruction did not occur. On the other hand, M2-state microglia were never observed around the vessels at this period. Interestingly, prior to M1 activation, about 55% of perivascular microglia transiently expressed Ki-67, one of the cell proliferation markers.
Conclusions:
We concluded that the resting perivascular microglia directly switched to the pro-inflammatory M1 state via a transient proliferative state in DOCA-salt rats. Our results suggest that the activation machinery of microglia in chronic hypertension differs from acute ischemic models. Proliferative microglia are possible initial key players in the development of hypertension-induced cerebral vessel damage. Fine-tuning of microglia proliferation and activation could constitute an innovative therapeutic strategy to prevent its development.
Insights
In chronic hypertension, microglia shift directly to a pro-inflammatory M1 state through proliferation, unlike in acute conditions. This suggests targeting microglia proliferation could prevent hypertension-related brain damage.
Area of Science:
- Neuroimmunology
- Cerebrovascular Research
- Hypertension Pathophysiology
Background:
- Microglia are key to brain homeostasis, with M1 (harmful) and M2 (beneficial) activation states.
- Microglia switch from M2 to M1 in acute ischemia, but their role in chronic hypertension is unclear.
- This study investigates microglial activation in a chronic hypertension model.
Purpose of the Study:
- To elucidate the microglial activation process in chronic hypertension.
- To compare microglial activation in chronic hypertension with acute ischemic models.
- To identify potential therapeutic targets for hypertension-induced cerebrovascular damage.
Main Methods:
- A deoxycorticosterone acetate (DOCA)-salt hypertension model in Wistar rats was used.
- Rats underwent unilateral nephrectomy and were treated with DOCA and salt.
- Immunohistochemical and biochemical analyses assessed microglial markers (M1/M2) and proliferation (Ki-67) at 2, 3, and 4 weeks.
Main Results:
- Hypertension developed by week 2, with initial perivascular microglia changes.
- M1 microglia significantly increased by week 3, preceding observed histopathological changes.
- Perivascular microglia transiently expressed Ki-67 (proliferation marker) before M1 activation; M2 microglia were not observed.
Conclusions:
- Resting perivascular microglia in chronic hypertension transition directly to the M1 state via proliferation.
- Microglial activation in chronic hypertension differs from acute ischemic models.
- Targeting microglia proliferation and activation may offer a novel therapeutic strategy for hypertension-induced vascular damage.
Related Concept Videos
Abnormal Proliferation
Series R—L Circuit Transients
Using Kirchhoff's Voltage Law (KVL) to analyze this circuit helps determine the total asymmetrical fault current, which consists...
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Cells Coordinate Growth and Proliferation

